QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.104.001321v1 66/6/1491    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kortagere, S. Articles by Schetz, J. A. Search for Related Content PubMed PubMed Citation Articles by Kortagere, S. Articles by Schetz, J. A.

Certain 1,4-Disubstituted Aromatic Piperidines and Piperazines with Extreme Selectivity for the Dopamine D4 Receptor Interact with a Common Receptor Microdomain

Department of Physiology & Biophysics, Weill Medical College of Cornell University, New York, New York (S.K., H.W.); Department of Medicinal Chemistry, Emil Fischer Center, Friedrich-Alexander University, Erlangen, Germany (P.G.); Department of Pharmacology & Neuroscience, University of North Texas Health Science Center, Fort Worth, Texas (J.A.S.); and Department of Pharmacology, School of Pharmacy, University of Mississippi, University, Mississippi (J.A.S.)

We previously demonstrated that, in the D4 dopamine receptor, the aromatic microdomain that spans the interface of the second and third transmembrane segments influences the high-affinity interactions with the D4-selective ligand L750,667 [3-{[4-(4-iodophenyl) piperazin-1-yl]methyl}-1H-pyrrolo[2,3-b]pyridine] and the D2-selective ligands methylspiperone, aripiprazole, and its congener OPC4392 [7-[3-(4-(2,3-dimethylphenyl) piperazinyl) propoxy] 2-(1H)-quinolinone] (Schetz et al., 2000). Here we tested a variety of 1,4-disubstituted aromatic piperidines/piperazines (1,4-DAPs) with different subtype selectivities and functional properties against a panel of D4 receptor mutations in the aromatic microdomain to ascertain whether these ligands recognize this common site. Mutant D4 receptors were constructed by substituting the nonconserved amino acid(s) from the corresponding locations in the D2 receptor. The D4-L2.60W, D4-F2.61V, and D4-LM3.28-3.29FV substitutions result in alterations of the relative position of members of the aromatic microdomain. From these results and molecular models of the ligand-receptor complexes, we conclude that 9 of the 11 D4-selective 1,4-DAPs, including L750,667, have a common pattern of ligand-receptor recognition that depends upon favorable interactions with the phenylalanine at position 2.61 (D4-F2.61V, 20-96-fold decrease). Like methylspiperone, aripiprazole, and OPC4392, the two D4-selective 1,4-DAPs that are insensitive to the D4-F2.61V mutation are sensitive to aromatics at position 2.60 (D4-L2.60W, 7-20-fold increase), and they all have longer spacer arms that permit their tethered aromatics to adopt alternative orientations in the binding-site crevice. All 11 of the D4-selective 1,4-DAPs were sensitive to the D4-LM3.28-3.29FV mutation (13-494-fold decrease) but not the moderately D2-selective methylspiperone. The inferences suggest that subtype selectivity involves two different modes of interaction with the microdomain for the D4-selective 1,4-DAPs and a third mode for D2-selective 1,4-DAPs.

Address correspondence to: Dr. John A. Schetz, Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, 3500 Camp Bowie Blvd., Fort Worth, TX 76107-2699. E-mail: jschetz{at}hsc.unt.edu

This article has been cited by other articles:

				S. S. Ericksen, D. F. Cummings, H. Weinstein, and J. A. Schetz Ligand Selectivity of D2 Dopamine Receptors Is Modulated by Changes in Local Dynamics Produced by Sodium Binding J. Pharmacol. Exp. Ther., January 1, 2009; 328(1): 40 - 54. [Abstract] [Full Text] [PDF]

				M. A. Al-Fulaij, Y. Ren, M. Beinborn, and A. S. Kopin Identification of Amino Acid Determinants of Dopamine 2 Receptor Synthetic Agonist Function J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 298 - 307. [Abstract] [Full Text] [PDF]

				H. Lan, C. J. DuRand, M. M. Teeter, and K. A. Neve Structural Determinants of Pharmacological Specificity Between D1 and D2 Dopamine Receptors Mol. Pharmacol., January 1, 2006; 69(1): 185 - 194. [Abstract] [Full Text] [PDF]